Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/121762
Título: | Seroprevalence of Strongyloides stercolaris in Patients about to Receive Immunosuppressive Treatment in Gran Canaria (Spain) | Autores/as: | Carranza Rodríguez, Cristina López Delgado, Laura Granados Magan, Álvaro Pérez Arellano, José Luis |
Clasificación UNESCO: | 32 Ciencias médicas 320505 Enfermedades infecciosas |
Palabras clave: | Biological Therapies Kidney Transplantation Strongyloides Stercoralis |
Fecha de publicación: | 2023 | Publicación seriada: | Tropical Medicine and Infectious Disease | Resumen: | Strongyloides stercoralis infection is generally asymptomatic or mildly symptomatic, but in the immunosuppressed host, it is associated with more severe and complicated forms with a worse prognosis. S. stercoralis seroprevalence was studied in 256 patients before receiving immunosuppressive treatment (before kidney transplantation or starting biological treatments). As a control group, serum bank data of 642 individuals representative of the population of the Canary Islands were retrospectively analyzed. To avoid false positives due to cross-reactivity with other similar helminth antigens present in the study area, IgG antibodies to Toxocara spp. and Echinococcus spp. were evaluated in cases positive for Strongyloides. The data show this is a prevalent infection: 1.1% of the Canarian population, 2.38% of Canarian individuals awaiting organ transplants and 4.8% of individuals about to start biological agents. On the other hand, strongyloidiasis can remain asymptomatic (as observed in our study population). There are no indirect data, such as country of origin or eosinophilia, to help raise suspicion of the disease. In summary, our study suggests that screening for S. stercoralis infection should be performed in patients who receive immunosuppressive treatment for solid organ transplantation or biological agents, in line with previous publications. | URI: | http://hdl.handle.net/10553/121762 | ISSN: | 2414-6366 | DOI: | 10.3390/tropicalmed8030181 | Fuente: | Tropical Medicine and Infectious Disease[EISSN 2414-6366],v. 8 (3), (Marzo 2023) |
Colección: | Artículos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.